|
VPS13D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.79209999565211E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84520000001687E-06 |
| Normal-vs-Stage2 |
4.19160000000307E-05 |
| Normal-vs-Stage3 |
4.564300E-03 |
| Normal-vs-Stage4 |
6.57290000205535E-08 |
| Stage1-vs-Stage2 |
5.010600E-01 |
| Stage1-vs-Stage3 |
7.894600E-01 |
| Stage1-vs-Stage4 |
2.243300E-03 |
| Stage2-vs-Stage3 |
7.193400E-01 |
| Stage2-vs-Stage4 |
1.219990E-01 |
| Stage3-vs-Stage4 |
6.107500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.35489999406747E-09 |
| Normal-vs-AfricanAmerican |
2.615300E-04 |
| Normal-vs-Asian |
3.88730000000503E-05 |
| Caucasian-vs-AfricanAmerican |
7.364100E-02 |
| Caucasian-vs-Asian |
3.081000E-01 |
| AfricanAmerican-vs-Asian |
7.082000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.5370000544811E-09 |
| Normal-vs-Female |
1.764370E-03 |
| Male-vs-Female |
2.615800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.358160E-03 |
| Normal-vs-Extreme_Weight |
7.86229970017871E-11 |
| Normal-vs-Obese |
6.018500E-04 |
| Normal-vs-Extreme_Obese |
5.407800E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.178400E-01 |
| Normal_Weight-vs-Obese |
8.649400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.826200E-01 |
| Extreme_Weight-vs-Obese |
1.626760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.124100E-02 |
| Obese-vs-Extreme_Obese |
3.783400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.077900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.91200000013659E-07 |
| Normal-vs-Age(61-80Yrs) |
1.14820000174376E-08 |
| Normal-vs-Age(81-100Yrs) |
1.27380000003452E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.199600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.106200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.434610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.686580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.420040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.909200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.67308397638999E-12 |
| Normal-VS-Type2 PRCC |
3.30280000016003E-07 |
| Normal-VS-KIRP CIMP |
1.910410E-01 |
| Normal-VS-Unclassified PRCC |
9.424100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.093800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.409200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.368800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.690400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.671200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.884200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78999999999041E-05 |
| Normal-vs-N1 |
8.599500E-04 |
| Normal-vs-N2 |
2.418000E-03 |
| N0-vs-N1 |
6.242000E-01 |
| N0-vs-N2 |
5.879200E-01 |
| N1-vs-N2 |
8.068600E-01 |
|
|
